Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety

Stem Cells and Development

Volumn 24, Issue 12, 2015, Pages 1390-1404

  Vahdat, Sadaf ^a,b   Mousavi, Seyed Ahmad ^a   Omrani, Gholamreza ^c   Gholampour, Maziar ^c   Sotoodehnejadnematalahi, Fattah ^a   Ghazizadeh, Zaniar ^a   Gharechahi, Javad ^a   Baharvand, Hossein ^a,d   Salekdeh, Ghasem Hosseini ^a,e   Aghdami, Nasser ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

^e Agricultural Biotechnology Research Institute of Iran   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL ISOLATION; CELL REGENERATION; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; EXPLANT; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION; ANIMAL; BIOLOGICAL THERAPY; CARDIAC MUSCLE CELL; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CYTOLOGY; GENETICS; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; STEM CELL;

RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-KIT; RATS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84930461310     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0222     Document Type: Article

References (73)

1. Lozano R, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, J Abraham, T Adair, R Aggarwal, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
2. Finegold JA, P Asaria and DP Francis. (2013). Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 168:934-945.
3. Smith RR, L Barile, E Messina and E Marban. (2008). Stem cells in the heart: what's the buzz all about? Part 2: arrhythmic risks and clinical studies. Heart Rhythm 5:880-887.
4. Files MD and RJ Boucek. (2012). 'Shovel-Ready' applications of stem cell advances for pediatric heart disease. Curr Opin Pediatr 24:577-583.
5. Makkar RR, RR Smith, K Cheng, K Malliaras, LE Thomson, D Berman, LS Czer, L Marban, A Mendizabal, et al. (2012). Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 379:895-904.
6. Bolli R, AR Chugh, D D'Amario, JH Loughran, MF Stoddard, S Ikram, GM Beache, SG Wagner, A Leri, et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857.
7. Zhao X and L Huang. (2013). Cardiac stem cells: a promising treatment option for heart failure. Exp Ther Med 5:379-383.
8. Mishra R, K Vijayan, EJ Colletti, DA Harrington, TS Matthiesen, D Simpson, SK Goh, BL Walker, G Almeida-Porada, et al. (2011). Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 123:364-373.
9. Smith RR, L Barile, E Messina and E Marban. (2008). Stem cells in the heart: what's the buzz all about?-Part 1: preclinical considerations. Heart Rhythm 5:749-757.
10. Beltrami AP, L Barlucchi, D Torella, M Baker, F Limana, S Chimenti, H Kasahara, M Rota, E Musso, et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
11. Oh H, SB Bradfute, TD Gallardo, T Nakamura, V Gaussin, Y Mishina, J Pocius, LH Michael, RR Behringer, et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100:12313-12318.
12. Messina E, L De Angelis, G Frati, S Morrone, S Chimenti, F Fiordaliso, M Salio, M Battaglia, MV Latronico, et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95:911-921.
13. Bearzi C, M Rota, T Hosoda, J Tillmanns, A Nascimbene, A De Angelis, S Yasuzawa-Amano, I Trofimova, RW Siggins, et al. (2007). Human cardiac stem cells. Proc Natl Acad Sci USA 104:14068-14073.
14. Zaruba MM, M Soonpaa, S Reuter and LJ Field. (2010). Cardiomyogenic potential of C-kit( + )-expressing cells derived from neonatal and adult mouse hearts. Circulation 121:1992-2000.
15. D'Amario D, C Fiorini, PM Campbell, P Goichberg, F Sanada, H Zheng, T Hosoda, M Rota, JM Connell, et al. (2011). Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 108:857-861.
16. Tang YL, L Shen, K Qian and MI Phillips. (2007). A novel two-step procedure to expand cardiac Sca-1 + cells clonally. Biochem Biophys Res Commun 359:877-883.
17. Davis DR, E Kizana, J Terrovitis, AS Barth, Y Zhang, RR Smith, J Miake and E Marban. (2010). Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. J Mol Cell Cardiol 49: 312-321.
18. Carr CA, DJ Stuckey, JJ Tan, SC Tan, RS Gomes, P Camelliti, E Messina, A Giacomello, GM Ellison and K Clarke. (2011). Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks-an MRI study. PLoS One 6:e25669.
19. Ye J, A Boyle, H Shih, RE Sievers, Y Zhang, M Prasad, H Su, Y Zhou, W Grossman, HS Bernstein and Y Yeghiazarians. (2012). Sca-1 + cardiosphere-derived cells are enriched for Isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One 7:e30329.
20. Smits AM, P van Vliet, CH Metz, T Korfage, JP Sluijter, PA Doevendans and MJ Goumans. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4:232-243.
21. Ellison GM, B Nadal-Ginard and D Torella. (2012). Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment. J Cardiovasc Transl Res 5:667-677.
22. Wilson A, LA Shehadeh, H Yu and KA Webster. (2010). Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells. BMC Genomics 11:229.
23. Lee MY, Y Wang and PM Vanhoutte. (2010). Senescence of cultured porcine coronary arterial endothelial cells is associated with accelerated oxidative stress and activation of NFkB. J Vasc Res 47:287-298.
24. Apitz C, GD Webb and AN Redington. (2009). Tetralogy of Fallot. Lancet 374:1462-1471.
25. Matsuura K, T Nagai, N Nishigaki, T Oyama, J Nishi, H Wada, M Sano, H Toko, H Akazawa, et al. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279:11384-11391.
26. Fathi A, M Hatami, V Hajihosseini, F Fattahi, S Kiani, H Baharvand and GH Salekdeh. (2011). Comprehensive gene expression analysis of human embryonic stem cells during differentiation into neural cells. PLoS One 6:e22856.
27. Takagawa J, Y Zhang, ML Wong, RE Sievers, NK Kapasi, Y Wang, Y Yeghiazarians, RJ Lee, W Grossman and ML Springer. (2007). Myocardial infarct size measurement in the mouse chronic infarction model: comparison of areaand length-based approaches. J Appl Physiol 102:2104-2111.
28. Dai W, SL Hale, BJ Martin, JQ Kuang, JS Dow, LE Wold and RA Kloner. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112:214-223.
29. Barile L, E Messina, A Giacomello and E Marban. (2007). Endogenous cardiac stem cells. Prog Cardiovasc Dis 50: 31-48.
30. Leri A, J Kajstura and P Anversa. (2005). Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85:1373-1416.
31. Takamiya M, KH Haider and M Ashraf. (2011). Identification and characterization of a novel multipotent sub-population of Sca-1( + ) cardiac progenitor cells for myocardial regeneration. PLoS One 6:e25265.
32. Di Nardo P, G Forte, A Ahluwalia and M Minieri. (2010). Cardiac progenitor cells: potency and control. J Cell Physiol 224:590-600.
33. Li TS, K Cheng, ST Lee, S Matsushita, D Davis, K Malliaras, Y Zhang, N Matsushita, RR Smith and E Marban. (2010). Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells 28:2088-2098.
34. Chong JJ, V Chandrakanthan, M Xaymardan, NS Asli, J Li, I Ahmed, C Heffernan, MK Menon, CJ Scarlett, et al. (2011). Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9:527-540.
35. Chimenti I, RR Smith, TS Li, G Gerstenblith, E Messina, A Giacomello and E Marban. (2010). Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106:971-980.
36. Tang XL, G Rokosh, SK Sanganalmath, F Yuan, H Sato, J Mu, S Dai, C Li, N Chen, et al. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:293-305.
37. Li TS, K Cheng, K Malliaras, RR Smith, Y Zhang, B Sun, N Matsushita, A Blusztajn, J Terrovitis, et al. (2012). Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59:942-953.
38. Smith RR, L Barile, HC Cho, MK Leppo, JM Hare, E Messina, A Giacomello, MR Abraham and E Marban. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896-908.
39. Huang C, H Gu, Q Yu, MC Manukyan, JA Poynter and M Wang. (2011). Sca-1 + cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS One 6:e29246.
40. Fuentes T and M Kearns-Jonker. (2013). Endogenous cardiac stem cells for the treatment of heart failure. Stem Cells Cloning 6:1-12.
41. Nadal-Ginard B, GM Ellison and D Torella. (2014). The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. Stem Cell Res 13:615-630.
42. den Haan MC, RW Grauss, AM Smits, EM Winter, J van Tuyn, DA Pijnappels, P Steendijk, AC Gittenberger-De Groot, A van der Laarse, et al. (2012). Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. J Cell Mol Med 16:1508-1521.
43. Ye L, YH Chang, Q Xiong, P Zhang, L Zhang, P Somasundaram, M Lepley, C Swingen, L Su, et al. (2014). Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15:750-761.
44. Dey D, L Han, M Bauer, F Sanada, A Oikonomopoulos, T Hosoda, K Unno, P De Almeida, A Leri and JC Wu. (2013). Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res 112:1253-1262.
45. Babu GJ, DM Warshaw and M Periasamy. (2000). Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 50:532-540.
46. Barile L, I Chimenti, R Gaetani, E Forte, F Miraldi, G Frati, E Messina and A Giacomello. (2007). Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med 4 Suppl 1: S9-S14.
47. Partovian C and M Simons. (2008). Stem cell therapies in cardiovascular disease A "realistic" appraisal. Drug Discov Today Ther Strateg 5:73-78.
48. Zhu W, I Shiojima, Y Ito, Z Li, H Ikeda, M Yoshida, AT Naito, J Nishi, H Ueno, et al. (2008). IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454:345-349.
49. Li H, S Zuo, Z Pasha, B Yu, Z He, Y Wang, X Yang, M Ashraf and M Xu. (2011). GATA-4 promotes myocardial transdifferentiation of mesenchymal stromal cells via upregulating IGFBP-4. Cytotherapy 13:1057-1065.
50. Oikonomopoulos A, KI Sereti, F Conyers, M Bauer, A Liao, J Guan, D Crapps, JK Han, H Dong, et al. (2011). Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res 109: 1363-1374.
51. D'Amario D, MC Cabral-Da-Silva, H Zheng, C Fiorini, P Goichberg, E Steadman, J Ferreira-Martins, F Sanada, M Piccoli, et al. (2011). Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res 108:1467-1481.
52. Hsieh D, A Hsieh, B Stea and R Ellsworth. (2010). IGFBP2 promotes glioma tumor stem cell expansion and survival. Biochem Biophys Res Commun 397:367-372.
53. Zebedee Z and E Hara. (2001). Id proteins in cell cycle control and cellular senescence. Oncogene 20:8317-8325.
54. Yokota Y and S Mori. (2002). Role of Id family proteins in growth control. J Cell Physiol 190:21-28.
55. Meng Q, Z Jia, W Wang, B Li, K Ma and C Zhou. (2011). Inhibitor of DNA binding 1 (Id1) induces differentiation and proliferation of mouse embryonic carcinoma P19CL6 cells. Biochem Biophys Res Commun 412:253-259.
56. Zhao Q, AJ Beck, JM Vitale, JS Schneider, S Gao, C Chang, G Elson, SJ Leibovich, JY Park, et al. (2011). Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes. Dev Biol 349:53-64.
57. Imanishi T, T Hano, T Sawamura, S Takarada and I Nishio. (2002). Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells. Circ J 66:1060-1064.
58. Korem S, MB Resnick and Z Kraiem. (1999). Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells. J Clin Endocrinol Metab 84:3322-3327.
59. McCawley LJ and LM Matrisian. (2000). Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 6:149-156.
60. Stamenkovic I. (2003). Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448-464.
61. Kim HE, SS Dalal, E Young, MJ Legato, ML Weisfeldt and J D'Armiento. (2000). Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 106:857-866.
62. Sappino AP, J Huarte, D Belin and JD Vassalli. (1989). Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 109:2471-2479.
63. McMahon B and HC Kwaan. (2008). The plasminogen activator system and cancer. Pathophysiol Haemost Thromb 36:184-194.
64. Yoshizawa K, S Nozaki, H Kitahara, K Kato, N Noguchi, S Kawashiri and E Yamamoto. (2011). Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. Oncol Rep 26:1555-1560.
65. Thummarati P, S Wijitburaphat, A Prasopthum, A Menakongka, B Sripa, R Tohtong and T Suthiphongchai. (2012). High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis. World J Gastroenterol 18:244-250.
66. Dufourcq P, L Leroux, J Ezan, B Descamps, JM Lamaziere, P Costet, C Basoni, C Moreau, U Deutsch, T Couffinhal and C Duplaa. (2008). Regulation of endothelial cell cytoskeletal reorganization by a secreted frizzled-related protein-1 and frizzled 4-and frizzled 7-dependent pathway: role in neovessel formation. Am J Pathol 172:37-49.
67. Bergmann MW. (2010). WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res 107:1198-1208.
68. Silke J and DL Vaux. (2001). Two kinds of BIR-containing protein-inhibitors of apoptosis, or required for mitosis. J Cell Sci 114:1821-1827.
69. Lamers F, I van der Ploeg, L Schild, ME Ebus, J Koster, BR Hansen, T Koch, R Versteeg, HN Caron and JJ Molenaar. (2011). Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr Relat Cancer 18:657-668.
70. Mita AC, MM Mita, ST Nawrocki and FJ Giles. (2008). Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14:5000-5005.
71. Logarinho E and H Bousbaa. (2008). Kinetochore-microtubule interactions "in check" by Bub1, Bub3 and BubR1: The dual task of attaching and signalling. Cell Cycle 7:1763-1768.
72. Bolanos-Garcia VM and TL Blundell. (2011). BUB1 and BUBR1: multifaceted kinases of the cell cycle. Trends Biochem Sci 36:141-150.
73. Yao Y and W Dai. (2012). Mitotic checkpoint control and chromatin remodeling. Front Biosci 17:976-983.